HAE:NYE-Haemonetics Corporation

EQUITY | Medical Instruments & Equipment | New York Stock Exchange

Last Closing Price

USD 103.38

Change

+0.08 (+0.08)%

Market Cap

USD 5.34B

Volume

0.63M

Yahoo Analyst Target

USD 86.86 (-15.98%)

STA Analyst Target

USD 109.36 (5.79%)
Yahoo Analyst Rating

Verdict

STA Analyst Rating

Verdict

STA Verdict

Verdict

About

Haemonetics Corp is a health care company.It provides products to customers involved in the processing,handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes & reduce costs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-08-15 )

Largest Industry Peers for Medical Instruments & Equipment

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+0.63 (+0.25%)

USD 67.17B
BAX Baxter International Inc.

+0.54 (+0.76%)

USD 38.07B
BCR C.R. Bard Inc.

N/A

USD 24.14B
RMD ResMed Inc.

-1.12 (-1.03%)

USD 15.29B
COO The Cooper Companies Inc.

-1.82 (-0.71%)

USD 12.43B
TFX Teleflex Incorporated

+3.97 (+1.72%)

USD 10.76B
VAR Varian Medical Systems Inc.

-1.37 (-1.24%)

USD 10.01B
STE STERIS plc

-1.54 (-1.34%)

USD 9.55B
WST West Pharmaceutical Services I..

-2.36 (-2.01%)

USD 8.45B
HRC Hill-Rom Holdings Inc

-1.60 (-1.69%)

USD 6.18B

ETFs Containing HAE

JKJ iShares Morningstar Small.. 0.77 % 0.25 %

-2.26 (-1.24%)

USD 0.25B
SMLF iShares Edge MSCI Multifa.. 0.70 % 0.32 %

-0.53 (-1.21%)

USD 0.18B
IWO iShares Russell 2000 Grow.. 0.47 % 0.24 %

-3.01 (-1.42%)

USD 11.10B
VTWG Vanguard Russell 2000 Gro.. 0.43 % 0.20 %

-2.10 (-1.37%)

USD 0.30B
IWM iShares Russell 2000 0.24 % 0.20 %

-2.11 (-1.25%)

USD 45.97B
VTWO Vanguard Russell 2000 Ind.. 0.21 % 0.15 %

-1.68 (-1.24%)

USD 1.61B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Equipment)
Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 78.00% 100% A+ 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 78.00% 100% A+ 99% A+
Trailing 12 Months  
Capital Gain 142.68% 100% A+ 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 142.68% 100% A+ 99% A+
Trailing 5 Years  
Capital Gain 154.44% 50% F 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 154.44% 50% F 93% A
Average Annual (5 Year Horizon)  
Capital Gain 20.78% 69% D+ 91% A-
Dividend Return 20.78% 54% F 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.93% 15% F 10% F
Risk Adjusted Return 50.76% 23% F 48% F
Market Capitalization 2.01B 31% F 78% C+

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Equipment)
Ratio vs. Market
(New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 240.42 8% F 2% F
Price/Book Ratio 7.17 23% F 10% F
Price / Cash Flow Ratio 6.71 54% F 15% F
Price/Free Cash Flow Ratio 46.78 23% F 11% F
Management Effectiveness  
Return on Equity 2.97% 23% F 29% F
Return on Invested Capital 4.80% 23% F 30% F
Return on Assets 1.79% 31% F 42% F
Debt to Equity Ratio 38.75% 58% F 72% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

HAE:NYE-Haemonetics Corporation

EQUITY | Medical Instruments & Equipment | New York Stock Exchange

Last Closing Price

USD 103.38

Change

+0.08 (+0.08)%

Market Cap

USD 5.34B

Volume

0.63M

Yahoo Analyst Target

USD 86.86 (-15.98%)

STA Analyst Target

USD 109.36 (5.79%)
Yahoo Analyst Rating

Verdict

STA Analyst Rating

Verdict

STA Verdict

Verdict

Values as of: 2018-08-15